Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.20.2
Stockholders' Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 15, 2020
Jun. 23, 2020
Apr. 06, 2020
Feb. 27, 2020
Jan. 31, 2020
May 31, 2019
Feb. 28, 2019
Jan. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Jun. 30, 2020
Jun. 15, 2020
Mar. 27, 2020
Reverse stock split       1-for-10 basis                        
Common stock, shares authorized                 12,000,000   12,000,000   12,000,000 8,000,000 8,000,000 2,250,000
Common stock issued during period             7,023 7,023                
Warrants exercise, shares             7,023 7,023                
Share price per share             $ 10.80 $ 10.80                
Common stock issued during period, value             $ 75,848 $ 75,848   $ 2,130,936   $ 3,810,267        
Preferred stock, shares authorized                 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000      
Preferred stock, par value                 $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001      
Preferred stock, shares issued                 583 0 583 0 0      
Preferred stock, shares outstanding                 583 0 583 0 0      
Number of shares granted                     472,183   100,335      
Share based compensation                     $ 483,208 $ 403,768        
Share options exercised                            
Options exercise price                     $ 2.24          
Unrecognized share based compensation                     $ 1,074,095          
Weighted average remaining recognition period of unvested share options                     2 years 10 months 17 days          
Warrant exercised                     7,023        
2013 Equity Incentive Plan [Member]                                
Unvested compensation cost                 $ 15,740 $ 228,000 $ 15,740 $ 228,000        
Unrecognized deferred compensation expense to be recognized over remainder of year                 $ 7,870   $ 7,870          
2013 Stock Option Plan [Member]                                
Common stock issued during period 890,000                              
Common stock shares reserved for issuance 650,000               255,534   255,534          
2020 Stock Appreciation Rights Plan [Member]                                
Number of shares granted                     114,179          
Share options exercised                              
Options exercise price   $ 2.63                 $ 2.24          
Unrecognized share based compensation                     $ 216,149          
Weighted average remaining recognition period of unvested share options                     2 years 8 months 23 days          
Percentage for stock appreciation rights exercise price                     100.00%          
June 2018 Public Offering [Member]                                
Common stock issued during period               8,843                
Securities Purchase Agreement [Member]                                
Warrants to purchase shares of common stock                               512
Series D Convertible Preferred Stock [Member]                                
Common stock issued during period                     3,157,427          
Common shares issued for conversion of preferred shares                     6,109          
Preferred stock dividend, shares                     749,924          
Number of common stock issued for services                     25,851          
Preferred stock, shares outstanding                 250   250          
Shares converted                     166,044          
Series D Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]                                
Share issued and sold during period, shares         1,640                      
Preferred stock dividend rate         9.00%                      
Preferred stock conversion price per shares         $ 2.50                      
Preferred stock, description         In addition, a holder may at any time, alternatively, convert all, or any part, of its Series D Preferred Shares at an alternative conversion price, which equals the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price ("VWAP") of the Common Stock for a five (5) trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Shares being redeemed                      
Series D Preferred Stock [Member] | Securities Purchase Agreement [Member]                                
Preferred stock, par value         $ 1,000                      
Series E Convertible Preferred Stock [Member]                                
Common stock issued during period                     61,651          
Series E Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]                                
Share issued and sold during period, shares                     333          
Common shares issued for conversion of preferred shares                     48,544          
Preferred stock dividend rate                     9.00%          
20 Employees [Member]                                
Number of shares granted                     472,183          
Vesting period                     3 years          
5 Directors [Member]                                
Number of shares granted                     472,183          
Vesting period                     3 years          
5 Consultant [Member]                                
Number of shares granted                     472,183          
Vesting period                     3 years          
21 Employees [Member]                                
Number of shares granted                       440,263        
Vesting period                       4 years        
2 Consultant [Member]                                
Number of shares granted                       440,263        
Vesting period                       4 years        
President and Chief Executive Officer [Member] | 2020 Stock Appreciation Rights Plan [Member]                                
Common shares granted for the period   60,094                            
Vice President [Member] | 2020 Stock Appreciation Rights Plan [Member]                                
Common shares granted for the period   12,019                            
Chief Technology Officer [Member] | 2020 Stock Appreciation Rights Plan [Member]                                
Common shares granted for the period   24,038                            
Chief Financial Officer [Member] | 2020 Stock Appreciation Rights Plan [Member]                                
Common shares granted for the period   18,028                            
Dawson James Securities, Inc [Member] | Placement Agent [Member]                                
Warrants to purchase shares of common stock     41,237                          
Pre-funded Warrants [Member]                                
Warrants to purchase shares of common stock     22,438                          
Warrants exercise price     $ 3.64                          
Series A Warrants [Member]                                
Warrants to purchase shares of common stock     515,465                          
Stock Options [Member]                                
Share based compensation                     $ 467,468 $ 400,768        
Common Stock [Member]                                
Share issued and sold during period, shares                       40,000        
Common stock issued during period                   307,500   447,580        
Common shares issued for conversion of preferred shares                 1,555,550   3,157,427          
Preferred stock dividend, shares                 339,499   749,924          
Number of common stock issued for services                 8,334 8,334 20,000        
Common stock issued during period, value                   $ 308   $ 448        
Common Stock [Member] | Series D Convertible Preferred Stock [Member]                                
Common stock issued during period                 1,895,049              
Common shares issued for conversion of preferred shares                     260,089          
Warrant exercised                 3,568              
Preferred Warrants [Member]                                
Warrant outstanding                 392   392          
Public Offering [Member]                                
Share issued and sold during period, shares     493,027                          
Warrants to purchase shares of common stock                   42,024   42,024        
Proceeds from public offering     $ 1,230,000                 $ 3,810,267        
Common stock issued during period                       447,580        
Number of common stock issued for services                       22,650        
Private Placement [Member]                                
Warrants to purchase shares of common stock           22,000                    
Common stock issued during period           40,000                    
Proceeds from private placement           $ 515,000                    
Private Placement [Member] | Series D Preferred Stock [Member]                                
Warrants to purchase shares of common stock         6,156                      
Warrants exercise price         $ 975                      
Warrants expiration date         Feb. 15, 2021